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There are no good statistics available with regard to the
prevalence, treatment patterns and results of treatment of
valvular heart disease in South Africa. However, most
practitioners with experience in the area agree that valvular
heart disease remains common and is not managed well. The
reasons why patients with valvular heart disease are not
recognised and treated appropriately are complex.  Blame can
be apportioned to many aspects of the system of medical care
available to such patients, and as much as I am a part of that
system I must acknowledge a degree of responsibility for any
deficiencies. It is worth examining and discussing the previous
and current situation so that we can devise strategies to
improve the care we provide in the future.
Before the mid-1980s South African clinician scientists made
significant contributions to knowledge in the area of valvular
heart disease.  The mitral valve prolapse syndrome and
features of sub-mitral aneurysm were first described in South
Africa. Large observational studies described management of
patients with a variety of manifestations of valvular heart
disease, which were mainly rheumatic in aetiology.  Reports of
the beneficial effects of successful mitral valve repair or
valvotomy, valve replacement surgery in acute rheumatic
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carditis and infective endocarditis altered practice.
Percutaneous balloon valvuloplasty was demonstrated to be
safe and effective in pregnancy and superior to surgical relief
of obstruction.  Beta-blockers were demonstrated to be effective
and safe in mitral stenosis.  Significant new information
regarding ventricular function in patients with valvular
regurgitation was published.
There has been little published information on the
prevalence of valvular heart disease or optimal management of
such patients in South Africa since the mid-1980s.  We have to
enquire why this is so.  The World Health Organization (WHO)
report of 2001
1
indicates that rheumatic heart disease remains
common in Africa and is responsible for significant premature
death and disability compared with the situation in the
developed world. There is no reason to suggest that the
situation is any different in South Africa, and this is congruent
with clinical opinion and experience.  In the only good local
survey of which I am aware, conducted in Soweto in the 1970s,
2
a team of clinicians evaluated a representative sample of 12 050
black schoolchildren and three observers in agreement
concluded that the prevalence rate of rheumatic heart disease
was 6.9/1 000.
2
This is in the same range as is currently
reported in other areas in Africa.1
It is well recognised that symptomatic disease may only
manifest decades afterwards and therefore if the observations
of the Soweto researchers are correct, there are now tens of
thousands of patients with chronic rheumatic valvular heart
disease in this country.  The experience of those treating
patients in the vulnerable population groups suggests that
these observations are correct.  Valve replacement surgery or
repair offers symptomatic benefit and may sometimes improve
prognosis.  Why is it then that valve surgery has become less
common in South Africa?  I will argue that five factors (some of
which are interrelated) impact negatively on patient care. These
are the privatisation of health care, altered state resource
allocation, inappropriate priority given to patients with
coronary disease, our professional educational system and the
impact of the HIV epidemic.
Privatisation of health care
We have celebrated the 10th anniversary of democracy in our
country which offers equality for all, but the fact is that for
patients with valvular heart disease we remain a nation
divided by the costs of health care. Care of patients with
valvular heart disease is expensive. Affluent patients, or those
with medical aid (20% of the population), have access in the
private sector to the very best medical care available.  Valve
disease in this patient group is uncommon and is usually
degenerative, affecting primarily older patients.  As in most of
the developed world, coronary disease is the major problem,
and valve disease in young patients is uncommon.  The impact
of the HIV epidemic has not yet manifested in these patients.
In stark contrast, those patients (80% of the population) who
are not affluent and who do not have access to medical aid or
are indigent rely on the state for their medical care. Most such
patients are young and have rheumatic or other infective
disease as the cause of their heart disease.  HIV infection is
common in these patients and inevitably influences the care
they receive.
In common with virtually all categories of health care
workers the majority (more than 70%) of registered cardiac
surgeons, cardiologists and cardiac clinical technologists in
South Africa work in the private sector.
The personnel resources required to diagnose and effectively
treat young patients with valvular heart disease in the
population dependent on the state are severely depleted.
Altered state resource allocation
Definitive surgical treatment of patients with valvular heart
disease is a tertiary care function.  National health policy
currently emphasises primary and secondary care and the
budgetary changes consequent on that emphasis mean that
over the last 5 years budgets of some tertiary care hospitals
have diminished (they have certainly not increased in pace
with inflation).  It is to be hoped that in decades to come
expanded primary care services in combination with improved
socio-economic conditions will result in less rheumatic valvular
heart disease.  However, the short-term effect of the current
policy is that patients with established valve disease, in need of
surgical repair, are seriously disadvantaged.  Cardiac valve
surgery is expensive.  Individual high-cost items such as valve
prostheses or other ‘disposables’ are convenient targets for
financial managers when setting ‘quotas’.  In contrast, coronary
artery surgery, particularly off-pump surgery, is cheaper.
Patients with coronary disease displace those with valve
disease on waiting lists unless the managers of such lists are
extraordinarily vigilant.
The net result of privatisation and altered resource allocation
is that fewer and fewer patients with valvular heart disease are
being operated on in state hospitals.  The total number of
cardiac operations at my own hospital has declined and the
number of patients having valve surgery is half what it was
some years ago.  Fewer elective procedures are performed and
emergency procedures on sicker patients take precedence.
Similar trends are reported from other centres.  The
maintenance of competence and training of the next generation
of cardiac surgeons require exposure to adequate numbers of
procedures.  There are already concerns that registrars do not
get adequate experience in valve surgery; certainly they receive
much less than a decade ago.  A generation of cardiac surgeons
and cardiologists is being trained with inadequate exposure to
the most common cardiac condition in the majority of the
population of the country.
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This is particularly unfortunate as it is occurring just when
we are finally moving towards enrolling a group of trainees
and junior staff representative of the population we serve.
What a tragedy it would be if we end up training them for
practice in Europe or North America rather than in Africa
simply because the stringencies of our health care system
dictate this.
Inappropriate priority given to patients
with coronary disease
The cardiac and cardiac surgical literature is written by and for
a First-World audience where chronic rheumatic valve disease
has been all but eradicated.  The diagnosis and management of
degenerative vascular, particularly coronary vascular, disease is
the predominant topic.  Not unexpectedly, this influences our
practice to a large extent.  Medical staff, nurses and
paramedical teams understand the urgency of administration
of thrombolysis after ST-elevation myocardial infarction, risk
stratification after non ST-elevation myocardial infarction and
the value of coronary surgery in prolonging life in certain
subsets of patients.  Such patients are usually referred
promptly and urgently to specialist centres.  Sometimes it
seems that this is at the cost of patients with valve disease, who
are only referred late in the course of the illness after years of
treatment with diuretics and unpleasant symptoms and at a
stage when surgery may no longer be feasible or carries a high
risk.
The emphasis in professional
education
Inevitably professional education, both under- and
postgraduate, is influenced by international trends and
fashions.  Undergraduate curricula have been adapted to focus
specifically on the health needs of South African patients.  In
my view postgraduate training in cardiology has not adapted
appropriately.  Registrars concentrate on acquiring skills in
procedures such as percutaneous coronary interventions,
pacemaker implantation and arrhythmia ablation.  This is
driven by the imperatives both of learning skills in demand in
the private sector, and of completing the log-book which is a
condition of qualification enabling them to enter private
practice.  Procedures are easy to count and monitor.  The
careful clinical evaluation and skilful judgement so important
in the management of patients with valvular heart disease is
far more difficult to measure and evaluate.
Students, of course, will learn whatever they understand
they are likely to be examined on.  In this regard the
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examination of the Colleges of Medicine for the Certificate of
Competence is crucial.  The content of the examination should
fit the disease profile of the country.  In the recent past the
subject allocated the greatest number of marks was coronary
disease – a condition still relatively uncommon in the majority
of the population.  Very few questions have dealt with valvular
or pericardial disease.
Impact of HIV /AIDS
HIV/AIDS is the leading cause of death in South Africa and
the impact is greatest in the population under 40 years of age.
3
This is the population where rheumatic valvular heart disease
is commonest.  I believe the epidemic has and is influencing
the management of patients with valve disease.  Many
practitioners adopt a nihilistic or fatalistic approach when
faced with HIV-infected patients.  This is a reflection of a
combination of factors including fear of infection and
ignorance and insecurity about treatment and drug
interactions. The delay in implementing effective treatment
strategies in the public sector has almost certainly contributed
to this. The result is conscious or unconscious discrimination in
referral and selection for surgery when patients are known to
be infected with HIV or to have AIDS.
Clearly this is incorrect and must change.  The expected 5-
year survival of a 30-year-old patient on highly active anti-
retroviral therapy (HAART) with a CD4 count of 100/µl is as
good as or better than that after mitral valve replacement. Such
patients should not be denied the symptomatic benefit valve
replacement offers.
However, many important issues are unresolved in this area.
Among them are the following: (i) at what level of
immunosuppression is surgery safe and when is it futile?; (ii)
how does the availability of HAART influence this?; (iii) what
valve prostheses should be used in these patients?; (iv) how
should HAART be managed perioperatively?; and (v) how
does HAART interact with warfarin and other cardiac
medication?
I believe that very few cardiologists or cardiac surgeons in
South Africa can answer these questions authoritatively (I
certainly cannot).
Are there solutions?
It is much easier to describe the problems than to prescribe the
solution.  The challenge we face is to maintain skills and
competencies and provide adequate training in therapeutic
cardiac procedures applicable to all in the country and not to
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allow budgetary constraints or internationally fashionable
trends to influence our practice to such an extent that certain
groups of patients with specific diseases are disadvantaged.
There is much we can do.
1. We can continue to point out to policy makers that current
budgetary stringencies specifically disadvantage certain groups
of patients.  Rheumatic valvular heart disease is a disease of
young black South Africans and is very uncommon in whites.
Continuation of these budgetary policies for very much longer
will mean that even if the policies are ultimately reversed and
adequate funding to allow treatment of a reasonable number of
patients is made available, the necessary competencies will
have atrophied to such an extent that treatment may well be
impossible, ineffective or unsafe.  Retraining surgeons and
rebuilding units will be a costly affair.  A precious health care
resource, unique in sub-Saharan Africa, which should be
available to train cardiac surgeons and cardiologists for the
treatment of cardiac diseases that are common in Africa will be
lost and may well be irreplaceable.
2. We need to pay careful attention to the prioritisation of the
health care resources under our direct personal control to
ensure that they are distributed equitably.  Most patients with
coronary artery disease belong to vocal constituencies and are
more likely to insist on treatment.  Language barriers, lack of
telephonic contact, financial constraints and patients’ own
acceptance of an inadequate system mean that those with
rheumatic valve disease often do not get appropriate treatment,
are ‘lost’ off waiting lists or miss follow-up appointments.
3. Postgraduate cardiology and cardiac surgical training
needs to be aligned with the needs of an African country.  If
case numbers are not adequate then programme directors need
to point that out and they need the support of their universities
in debate with provincial health authorities.  Those who
allocate finances need to be made aware of the potential long-
term consequences of the short-term triumph of ‘remaining in
budget’.
4. The magnitude of the problem needs to be defined
accurately.  Budgets can only be allocated appropriately if
accurate statistics are available. Acute rheumatic fever is a
notifiable disease and it is our responsibility to ensure that
notification is done. This is a professional task often left to
junior staff.  Everyone has to take responsibility for ensuring
that notification has taken place and that the correct diagnoses
are entered on the discharge summaries.
5. We need to ensure that what we teach our registrars, how
we train them and what we examine them on is applicable to
the diseases affecting all the people of the country and not just
to the needs of those with access to private medical care.
6. A clear strategy needs to be developed for the
management of patients with valvular heart disease who are
HIV-positive or who have AIDS.  At present it seems that no
clear policy exists and the management of individual patients
depends as much on whim as on informed opinion.
Cardiologists and cardiac surgeons need to learn and
understand the impact of therapy on the natural history of the
condition and how it interacts with their own treatment.  Each
unit needs to develop a clear policy that is explicit and readily
available to staff at all levels so that patients are referred
appropriately for surgery and not discharged from lower levels
of care simply because they are HIV-positive.  At the same time
detailed records of outcomes need to be maintained to facilitate
clinical research to inform future management of this novel
combination of diseases that will remain important in Africa in
the foreseeable future.
Little of this is original and much has been addressed
previously in the wider field of medicine in general.
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However
it is important for each sub-specialty to consider how it should
best adapt to the challenges facing it to ensure that the patients
it serves obtain the best possible care under rapidly changing
and difficult circumstances.
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